We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant

Delisted

CYTXW was delisted on the 14th of December, 2018.

6 hedge funds and large institutions have $2.48M invested in Cytori Therapeutics Inc Warrant in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $1.74M → $2.48M (+$744K)

20% more funds holding

Funds holding: 56 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
+$17.1K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$1.55M -$90.4K -109,048 -11%
AFM
2
Anson Funds Management
Texas
$914K
Creative Planning
3
Creative Planning
Kansas
$17K +$17.1K +20,652 New
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$1K -$207 -250 -28%
KLI
5
Kelman-Lazarov Inc
Tennessee
$159

CYTXW Hedge Fund Activity: Q3 2016 in Review

6 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q3 2016, worth a combined $2.48M — up 43% from $1.74M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CYTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $17.1K. The largest seller was Sabby Management, cutting an estimated $90.4K.

  • 6 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q3 2016, up from 5 in Q2 2016.
  • Funds reported $2.48M of Cytori Therapeutics Inc Warrant stock for Q3 2016, up 43% quarter-over-quarter.
  • 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q3 2016 was Creative Planning, an estimated $17.1K added.
  • The largest Cytori Therapeutics Inc Warrant seller in Q3 2016 was Sabby Management, an estimated $90.4K sold.

Based on aggregated 13F filings for Q3 2016.